Multiple Myeloma | University of Iowa Clinical Research and Trials
The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Multiple Myeloma Clinical Trials & Emerging Therapies
- A single‑cell atlas of multiple myeloma defines malignant archetypes and proliferative states
- S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)
- Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
- Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy